The Share

Listed since 1987

The VBG Group’s Series B share is traded on Nasdaq Stockholm Mid Cap under the ticker VBG B. The Series A shares, which represent 52 per cent of the votes in the VBG Group, are held by three foundations: the Herman Krefting Foundation for Allergy and Asthma Research, the SLK Employees’ Foundation and the VBG-SLK Foundation.

Dividend and dividend policy

Since the company’s initial listing on the stock exchange in 1987, the company has paid an average dividend amounting to 33.6 per cent of the net profit. In March 2012, the Board of Directors adopted a policy stipulating 30 per cent as the level of the dividend the shareholders can expect under normal circumstances.

Share data

 

Per share data

     2017    2016 2015 2014 2013
Earnings, SEK 9.62 9.66 7.64 6.31 9.00
Dividend, SEK 3.25* 3.50(1.75**) 3.25 3.00 2.75
Share price, SEK 132.00 160.50 121.00 103.75 126.00
Share price adjusted, SEK (as regards new share issue) 132.00 111.19 83.83 71.88 87.29
P/E ratio 13.7 16.6 15.8 16.4 14.0
Equity, SEK 80.18 82.01 69.71 65.40 58.99
Cash flow from operating activities, SEK 10.63 20.08 11.61 9.81 10.30
Dividend yield, % 2.46 2.18 2.69 2.89 2.18
Total number of outstanding shares (thousands) 25,004 12,502 12,502 12,502 12,502
Average number of outstanding shares (thousands) 22,920 12,502 12,502 12,502 12,502

*Proposed dividend per share.
**Dividend per share based on doubling of the number of outstanding shares o 25,004,048 after the new share issue in February 2017.

Shareholders

Analysts monitoring the VBG Group

Karl Bokvist
ABG Sundal Collier
Tel: +46 8 566 286 33
E-mail: karl.bokvist@abgsc.se

ABG Sundal Collier monitors VBG Group's share via Introduce.